ClinicalTrials.gov
ClinicalTrials.gov Menu

Exercise Effects on Cardiovascular Risk Factors, Quality of Life, Muscle Function in Type 2 Diabetes and Healthy Persons (SMIDIG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00852982
Recruitment Status : Unknown
Verified February 2009 by Karolinska Institutet.
Recruitment status was:  Active, not recruiting
First Posted : February 27, 2009
Last Update Posted : March 2, 2009
Sponsor:
Information provided by:
Karolinska Institutet

Brief Summary:
A sedentary lifestyle is known to be a risk factor to developing type 2 diabetes. The aim of this study was to determine the effects of adding regular Nordic walking to daily physical activity. Effects on quality of life, cardiovascular risk factors and functions in muscle cells will be determined.

Condition or disease Intervention/treatment Phase
Type 2 Diabetes Impaired Glucose Tolerance Behavioral: Exercise Not Applicable

Detailed Description:

Regular physical activity is known to have a beneficial effect on several factors affecting the risk of developing cardiovascular disease and type 2 diabetes. Implementing and maintaining changes of lifestyle is, however, known to be difficult. In this study we wished to investigate the effects of an exercise intervention that is feasible to most people with type 2 diabetes or at risk of developing that disease. The intervention was Nordic walking (with walking poles) for five hour per week, during four months. We chose to determine effects on health related quality of life, clinical parameters related to body weight/body composition, blood pressure, glucose metabolism, insulin resistance, blood lipids, oxygen uptake and physiological effects in skeletal muscle cells related to glucose metabolism.

On inclusion and after four months the participants were therefore subject to clinical measurements, blood samples, maximal oxygen uptake tests on an ergometer cycle and muscle biopsies at inclusion and after four months of participation. They also answered an extensive questionnaire focusing on health related quality of life.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 213 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Exercise - Effects on Health Related Quality of Life, Cardiovascular Risk Factors, and Cellular Functions With Respect to Glucose Metabolism, in Type 2 Diabetes Mellitus, Impaired Glucose Tolerance and in Healthy Individuals.
Study Start Date : April 2006
Estimated Primary Completion Date : September 2009
Estimated Study Completion Date : September 2009

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Exercise
Five hours of Nordic walking per week, during four months
Behavioral: Exercise
Nordic walking, with walking poles, five hours per week during four months

No Intervention: Control
Control group asked not to alter lifestyle during study
Behavioral: Exercise
Nordic walking, with walking poles, five hours per week during four months




Primary Outcome Measures :
  1. HbA1c [ Time Frame: at inclusion and after four months ]

Secondary Outcome Measures :
  1. waist circumference [ Time Frame: at inclusion and after four months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   45 Years to 69 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • BMI>25

Exclusion Criteria:

  • Physical impairment
  • Symptomatic angina pectoris
  • Insulin treatment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00852982


Locations
Sweden
Primary health care center
Stockholm, Sweden, SE 134 40
Sponsors and Collaborators
Karolinska Institutet
Investigators
Principal Investigator: Juleen Zierath, Professor Dep. of molecular medicine and surgery, Karolinska Institutet

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Juleen Zierath , Professor, Dep. of molecular medicine and surgery, Karolinska Institutet
ClinicalTrials.gov Identifier: NCT00852982     History of Changes
Other Study ID Numbers: ALF 2006 03 25
First Posted: February 27, 2009    Key Record Dates
Last Update Posted: March 2, 2009
Last Verified: February 2009

Keywords provided by Karolinska Institutet:
Exercise
Risk factors
Primary health care

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Intolerance
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Hyperglycemia